How former drug company labs are becoming contract research firms

In Europe, facilities being spun off by drug companies are finding new life as multiclient R&D facilities

Source: NanoFocus - August 4, 2018 Category: Nanotechnology Authors: Sean Milmo, special to C & EN Source Type: research